Friday, Jul 3, 2026
  • Login
No Result
View All Result
Newz Daddy
  • Politics
    • Defence News
    • Gujarat Politics
    • Indian Politics
    • World News
  • Business & Finance
    • Markets
    • Companies
    • Insurance
    • Personal Finance
  • Entertainment
    • OTT Reviews
    • Bollywood Movies Reviews
    • Entertainment News
    • Gujarati Movies Review
  • Sports
    • Cricket
    • Football
    • IPL
      • IPL 2025
      • IPL 2026
  • Fashion and Lifestyle
    • Fashion
    • Health & Fitness
    • Relationships
    • Spirituality
    • Tourism & Travel
  • Education
  • Daily News
  • About Us
  • Contact Us
  • Politics
    • Defence News
    • Gujarat Politics
    • Indian Politics
    • World News
  • Business & Finance
    • Markets
    • Companies
    • Insurance
    • Personal Finance
  • Entertainment
    • OTT Reviews
    • Bollywood Movies Reviews
    • Entertainment News
    • Gujarati Movies Review
  • Sports
    • Cricket
    • Football
    • IPL
      • IPL 2025
      • IPL 2026
  • Fashion and Lifestyle
    • Fashion
    • Health & Fitness
    • Relationships
    • Spirituality
    • Tourism & Travel
  • Education
  • Daily News
  • About Us
  • Contact Us
No Result
View All Result
Newz Daddy
No Result
View All Result

Indraprastha Apollo Hospitals conducts Press Conference on Lung Transplant in Ahmedabad

Experts talk about advances in lung transplant

Newz Daddy Editor by Newz Daddy Editor
5 April 2022
Reading Time: 3 mins read
0
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on LinkedIn
Recent Visitors 39

 

April 2022: As a part of Apollo’s initiative of providing advanced treatment to people across the country, Indraprastha Apollo Hospitals, New Delhi conducted a Press Conference with the healthcare fraternity of Ahmedabad at Hotel Fairfield by Marriot.  Lead by, Dr. M S Kanwar, Lead Lung Transplant and COVID Team, Senior Consultant & Advisor Department of Pulmonology, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals the PRESS CONFERENCE addressed the complexities of Lung diseases along with the advanced treatment modalities available in India.

 

Addressing the Press Conference, Dr. M S Kanwar, Lead Lung Transplant and COVID Team, Senior Consultant & Pulmonologist, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals said, “The lung transplant is not just surgery but a process starting with extensive pre-lung transplant workup and optimal stabilization of the patients of end-stage lung diseases like IPF, COPD, Emphysema, Covid Fibrosis, Pulmonary Hypertension, and many others. It also involves lung and general rehabilitation, optimal oxygen therapy and positive pressure ventilation, ECMO, etc. Lung transplant surgery is complex and so is immediate and long-term post-operative care. Lung transplants which have been popular in advanced countries for decades with a constant annual increase in the number of lung transplants are now available in India also with comparable outcomes. Several international patients from other countries are currently under our treatment at Indraprastha Apollo Hospitals or waiting to be stabilized and transferred to our Hospitals in New Delhi for their lung transplant, in most cases a double lung transplant, said Dr. Kanwar.

 

Indraprastha Apollo Hospital is already a leading transplant center for kidney, liver, and bone marrow and has accomplished heart transplants also. According to Dr. Kanwar, the chief lung transplant surgeon in their program has about 170 lung and heart-lung transplants to his credit and we pride in one brilliant infrastructure and critical care that are essential components for a robust lung transplant program.”

Hence, patients should not let their guards down in terms of preventive health check-ups. Today the treatment modalities for treating the most complex lung diseases are available in India. As a reason, the patients should do away with the hesitancy of delaying diagnosis due to the fear of being diagnosed with any complex disease. A disease treated early always has better outcomes in terms of patient recovery.

About Indraprastha Apollo Hospitals:

Indraprastha Apollo Hospitals, India’s first JCI accredited hospital, is a joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited. Commissioned in July 1996, it is the third super-specialty tertiary care hospital set up by the Apollo Hospitals Group. Spread over 15 acres, it houses 57 specialties with more than 300 specialists and more than 700 operational beds, 19 operation theatres, 138 ICU beds, round-the-clock pharmacy, NABL accredited laboratories, 24-hour emergency services, and an active air ambulance service. Apollo Hospitals Delhi has the leading program in kidney and liver transplants in the country. The first successful pediatrics and adult liver transplants in India were performed at Indraprastha Apollo Hospitals. The hospital is at the forefront of medical technology and expertise. It provides a complete range of the latest diagnostic, medical, and surgical facilities for the care of its patients. The Hospital has introduced the most sophisticated imaging technology to India with the introduction of 64 slices CT and 3 Tesla MRI, Novalis Tx, and the integrated PET Suite. Indraprastha Apollo has also pioneered the concept of preventive health check programs and has created a satisfied customer base over decades. The Hospital has been consistently ranked among the best 10 hospitals in India by The Week survey for the past few years.

 

Hospital website –www.apollohospdelhi.com                      Twitter: @HospitalsApollo

For more information please contact:

Kusum Sahijpal- 9999973090: kusum_s@apollohospitalsdelhi.com

 

 

Previous Post

On April 5, 2022, the Redemption Codes for Garena Free Fire Max were released.

Next Post

The government is taking a harsh line against fake news, banning 22 YouTube channels.

Newz Daddy Editor

Newz Daddy Editor

Our news is our personal opinion. We do not intend to defame anyone. Newz matters the most. Information that is useful.

Next Post
photo source:Twitter.com

The government is taking a harsh line against fake news, banning 22 YouTube channels.

You might also like

  • Kia Tennis Premier League Adds Kia India to All Eight Teams
  • DAC Approves ₹52,000 Crore Defence Acquisitions for India
  • Indian Coast Guard Porbandar Jetty Gives Gujarat New Edge
  • Mayapur Guest House Opens as Pilgrim Footfall Rises in Nadia
  • Adani IRH Aluminium Project Odisha Promises 53,500 New Jobs

Categories

Newz Daddy

Newz Daddy is an English News Portal that covers all latest and breaking news on Sports, Entertainment, Business, Technology, Finance, Fashion, Health and Lifestyle many more news from India and across the globe.

Follow Us

Browse Category

Recent News

Kia Tennis Premier League Adds Kia India to All Eight Teams

Kia Tennis Premier League Adds Kia India to All Eight Teams

3 July 2026
DAC Approves ₹52,000 Crore Defence Acquisitions for India

DAC Approves ₹52,000 Crore Defence Acquisitions for India

3 July 2026
No Result
View All Result

Copyright 2026 newzdaddy.com. All right reserved.

  • About Us
  • Privacy & Policy
  • Terms & Conditions
  • Contact Us
No Result
View All Result
  • Aam Aadmi Party
  • About Us
  • All Indian Trinamool Congress – Party
  • Apply Now
  • Arvind Kejriwal
  • Bhartiya Janta Party – BJP
  • Bhartiya Janta Party Gujarat
  • Board of Control for Cricket in India (BCCI)
  • Congress
  • Contact Us
  • Fédération Internationale de Football Association – FIFA
  • Freebies
  • Home 1
  • Home 2
  • Home 3
  • Home 4
  • Home 5
  • Home 6
  • Mamta Banerjee
  • Policy on Privacy and Cookies
  • Rahul Gandhi
  • Rashtriya Raksha University (RRU)
  • Shri Narendra Modi
  • Shri Rajnath Singh
  • Terms and Conditions
  • The Adani Group
  • The Indian Air Force
  • The Indian Army
  • The Indian Navy
  • The International Cricket Council

Copyright 2026 newzdaddy.com. All right reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version